CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 87 filers reported holding CYTOSORBENTS CORP in Q4 2018. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 1,772,000 | $13,379,000 | 1.58% |
| Sargent Investment Group, LLC | 856,315 | $6,465,000 | 1.53% |
| Avenir Corp | 1,366,549 | $10,317,000 | 0.82% |
| CM Management, LLC | 150,000 | $1,133,000 | 0.82% |
| Winning Points Advisors, LLC | 136,900 | $1,035,000 | 0.78% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,397,000 | 0.46% |
| SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,847,000 | 0.15% |
| Redmile Group, LLC | 1,304,369 | $9,848,000 | 0.15% |
| Granahan Investment Management | 1,003,546 | $7,577,000 | 0.14% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $265,000 | 0.14% |